FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Hetero Labs Limited (Unit V) Pantoprazole Sodium Recall

Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, M…

Hetero Labs Limited (Unit V) · Mahabubnagar, N/A

Risk level
Class II
Reported by FDA
Apr 29, 2026
Recall ID
D-0484-2026
Check your lot numberHow we source this data

Summary

Hetero Labs Limited (Unit V) recalled Pantoprazole Sodium starting Mar 26, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0484-2026 on Apr 29, 2026. Reason: Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots.". Status: Ongoing.

Why it was recalled

Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."

Product description

Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10

Lot numbers, UPCs & expiration codes

Batch # FD253967, Exp Date: 06/26/2027

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0484-2026
Classification
Class II
Status
Ongoing
Recall initiated
Mar 26, 2026
FDA report date
Apr 29, 2026
Quantity
4,740 1,000-count bottles.
Recall type
Voluntary: Firm initiated
Recalling firm
Hetero Labs Limited (Unit V)

Original FDA data

Every field from FDA enforcement report D-0484-2026, exactly as published.

Show all FDA fields
City
Mahabubnagar
Status
Ongoing
Country
India
Event ID
98671
Address
Unit V, Sy. No.: 439,440,441&458
Address (line 2)
Tsiic Formulation Sez, Polepally Village
Code information
Batch # FD253967, Exp Date: 06/26/2027
Report date
Apr 29, 2026
Product type
Drugs
Recall number
D-0484-2026
Classification
Class II
Recalling firm
Hetero Labs Limited (Unit V)
Product quantity
4,740 1,000-count bottles.
Reason for recall
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10
Distribution pattern
Nationwide in the USA.
Recall initiation date
Mar 26, 2026
Center classification date
Apr 17, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0484-2026, published Apr 29, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls